Polycystic Ovary Syndrome(PCOS) and diminished ovarian reserve(DOR)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Women aged 18–47 seeking reproductive services at the hospital; 2) In the early follicular phase on the day of the visit, particularly days 2–4 of the menstrual cycle; 3) No prior diagnosis of PCOS or DOR; 4) Blood tests on the day of the visit include measurement of FSH and LH hormone levels; 5) Legally competent to understand this study and sign an informed consent form; 6) Willing to complete a questionnaire and voluntarily undergo urine testing using the target trial’s urine test kit;
Exclusion criteria
Exclusion criteria: 1) Pregnant or breastfeeding women; 2) Women with metabolic or endocrine disorders; 3) Women with a history of ovarian surgery; 4) Women with a history of ovarian, fallopian tube, or uterine abnormalities or lesions; 5) Postmenopausal women; 6) Women who have used combined oral contraceptives (COC) within the past three months prior to enrollment; 7) Patients who, for various reasons, do not wish to participate in this study; 8) Women seeking reproductive services at this hospital due to reasons unrelated to endocrine disorders, such as male sperm quality issues or tubal blockage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary follicle-stimulating hormone (FSH) level detected by urine test kit;Urinary luteinizing hormone (LH) level detected by urine test kit;Accuracy;Sensitivity;Specificity; | — |
Countries
China
Contacts
The West China School of Public Health